With strong revenue growth projections, Mesoblast Limited (NASDAQ:MESO) secures a spot on our list of the best long-term ASX stocks to buy right now. Mesoblast Limited (MESO), One of the Best Long-Term ASX Stocks To Buy Right Now; See Why As of April 15, 2026, all covering analysts remain bullish on Mesoblast Limited (NASDAQ:MESO), with a consensus price target of $32.5, implying upside potential of 106.5%. That positive sentiment is largely driven by Ryoncil’s growing clinical potential and expanding c ...